G

Generation Bio Co
D

GBIO

0.60660
USD
-0.01
(-1.49%)
مغلق
حجم التداول
16,050
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
40,516,526
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BEAM
    -2.705
    (-8.16%)
    30.445 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    IDXX
    IDXX
    -0.33
    (-0.07%)
    452.66 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Generation Bio Co

القطاع: Healthcare
الصناعة: Biotechnology
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.